Literature DB >> 12631343

Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II.

Edwina K Rice1, Gregory H Tesch, Zemin Cao, Mark E Cooper, Christine N Metz, Richard Bucala, Robert C Atkins, David J Nikolic-Paterson.   

Abstract

BACKGROUND: Angiotensin II (Ang II) plays an important role in the development of renal injury through its vasoactive and proinflammatory activities. We investigated whether some of the effects of Ang II could be mediated through the production of macrophage migration inhibitory factor (MIF).
METHODS: Groups of rats underwent sham surgery (sham), subtotal nephrectomy (STNx), or STNx plus treatment with irbesartan. Renal tissue was examined 12 weeks postsurgery for MIF mRNA expression and leukocyte accumulation. To determine whether Ang II had a direct effect on MIF production, mRNA synthesis and protein secretion were examined in proximal tubular epithelial (NRK52E and MCT) cell lines.
RESULTS: MIF mRNA was strongly expressed in 5.4%+/- 1.1% (mean +/- SD) of cortical tubules of sham-operated rats. This was significantly up-regulated in STNx rats (44.9%+/- 22.6%) and was abrogated by administration of irbesartan (2.8%+/- 2.4%). STNx resulted in significant glomerular and interstitial accumulation of macrophages and T cells, which correlated with glomerular and tubular MIF mRNA expression, respectively. In vitro studies of tubular epithelial cells revealed that Ang II caused a twofold increase in MIF mRNA expression in NRK52E and MCT cells, which was abrogated by irbesartan. In addition, Ang II induced a rapid release of 50% of MIF protein from NRK52E cells within 20 minutes.
CONCLUSION: This study has demonstrated that Ang II up-regulates MIF mRNA production and MIF protein secretion by tubular epithelial cells. Ang II may promote accumulation and activation of interstitial leukocytes via induction of MIF synthesis and secretion in renal tubular epithelial cells. This may be an important mechanism by which Ang II mediates renal injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631343     DOI: 10.1046/j.1523-1755.2003.00875.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer.

Authors:  Hiroji Uemura; Hisashi Hasumi; Takashi Kawahara; Shinpei Sugiura; Yasuhide Miyoshi; Noboru Nakaigawa; Jun-ichi Teranishi; Kazumi Noguchi; Hitoshi Ishiguro; Yoshinobu Kubota
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.402

2.  Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.

Authors:  Jinhong Li; Ying Tang; Patrick M K Tang; Jun Lv; Xiao-Ru Huang; Christine Carlsson-Skwirut; Lydie Da Costa; Anna Aspesi; Suada Fröhlich; Pawel Szczęśniak; Philipp Lacher; Jörg Klug; Andreas Meinhardt; Günter Fingerle-Rowson; Rujun Gong; Zhihua Zheng; Anping Xu; Hui-Yao Lan
Journal:  Mol Ther       Date:  2018-07-17       Impact factor: 11.454

3.  The MIF receptor CD74 in diabetic podocyte injury.

Authors:  Maria Dolores Sanchez-Niño; Ana Belen Sanz; Pekka Ihalmo; Markus Lassila; Harry Holthofer; Sergio Mezzano; Claudio Aros; Per-Henrik Groop; Moin A Saleem; Peter W Mathieson; Robert Langham; Matthias Kretzler; Viji Nair; Kevin V Lemley; Robert G Nelson; Eero Mervaala; Deborah Mattinzoli; Maria Pia Rastaldi; Marta Ruiz-Ortega; Jose Luis Martin-Ventura; Jesus Egido; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-10-08       Impact factor: 10.121

Review 4.  The enigma of sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Peter A Ward
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

5.  Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production.

Authors:  Isha Dhande; Wanshu Ma; Tahir Hussain
Journal:  Hypertens Res       Date:  2014-09-11       Impact factor: 3.872

6.  Macrophage Migration Inhibitory Factor Mediates Proliferative GN via CD74.

Authors:  Sonja Djudjaj; Hongqi Lue; Song Rong; Marios Papasotiriou; Barbara M Klinkhammer; Stephanie Zok; Ole Klaener; Gerald S Braun; Maja T Lindenmeyer; Clemens D Cohen; Richard Bucala; Andre P Tittel; Christian Kurts; Marcus J Moeller; Juergen Floege; Tammo Ostendorf; Jürgen Bernhagen; Peter Boor
Journal:  J Am Soc Nephrol       Date:  2015-10-09       Impact factor: 10.121

7.  Anti-inflammatory renoprotective effect of clopidogrel and irbesartan in chronic renal injury.

Authors:  Xiaowen Tu; Xiangmei Chen; Yuansheng Xie; Suozhu Shi; Jianzhong Wang; Yunshuang Chen; Jianjun Li
Journal:  J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 10.121

8.  Prophylactic Add-on Antiplatelet Therapy in Chronic Kidney Disease With Type 2 Diabetes Mellitus: Comparison Between Clopidogrel and Low-dose Aspirin.

Authors:  Amitabh Dash; Rituparna Maiti; Tejaswi Kumar Akantappa Bandakkanavar; Amit Bhaskar; Jai Prakash; Bajarang Lal Pandey
Journal:  Int J Prev Med       Date:  2013-08

9.  Involvement of Src tyrosine kinase and protein kinase C in the expression of macrophage migration inhibitory factor induced by H2O2 in HL-1 mouse cardiac muscle cells.

Authors:  F Rao; C Y Deng; Q H Zhang; Y M Xue; D Z Xiao; S J Kuang; Q X Lin; Z X Shan; X Y Liu; J N Zhu; X Y Yu; S L Wu
Journal:  Braz J Med Biol Res       Date:  2013-09-06       Impact factor: 2.590

10.  Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation and Matrix Deposition in Kidney Tissues after Injury.

Authors:  Hong Lu; Yongyu Bai; Lianfeng Wu; Weilong Hong; Yong Liang; Bicheng Chen; Yongheng Bai
Journal:  Mediators Inflamm       Date:  2016-05-23       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.